Demand for malaria drug soars

Farmers and scientists struggle to keep up with needs of ambitious medicine-subsidy programme.

From bust to boom to bust again: artemisinin, the key ingredient of front-line antimalarial drugs, is entering the third chapter of its turbulent history, reports Richard Van Noorden in Nature News.

Read the full article.